Back
Diamondback Energy Vs. Spyre Therapeutics Industry Stock Comparison
Sell
25
FANG
Diamondback Energy
Last Price:
170.46
Seasonality Move:
9.98%
Buy
59
SYRE
Spyre Therapeutics
Last Price:
28.46
Seasonality Move:
-2.85%
Sell
25
Diamondback Energy (FANG)
is a Sell
Is Diamondback Energy a Buy, Sell or Hold?
- The current Diamondback Energy [FANG] share price is $168.91. The Score for FANG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- FANG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $29.04. The Score for SYRE is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- SYRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FANG Stock Price Chart
What is Diamondback Energy's stock price today?
-
The Diamondback Energy share price today is $168.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FANG is experiencing selling pressure, which indicates risk of future bearish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $29.04
The current trend is moderately bearish and SYRE is experiencing slight buying pressure.
FANG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.57 | Sell |
Relative Strength Index (14 RSI): | 34.15 | Sell |
Chaikin Money Flow: | -3432478 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (174.19 - 192.11) | Sell |
Bollinger Bands (100): | (184.72 - 203.38) | Sell |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.41 | Buy |
Relative Strength Index (14 RSI): | 53.02 | Buy |
Chaikin Money Flow: | 71063 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.98 - 29.52) | Buy |
Bollinger Bands (100): | (25.44 - 33.84) | Sell |
FANG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 180.07 | Sell |
20-day SMA: | 180.27 | Sell |
50-day SMA: | 190.16 | Sell |
200-day SMA: | 185.03 | Sell |
8-day EMA: | 178.45 | Sell |
20-day EMA: | 181.22 | Sell |
50-day EMA: | 187.33 | Sell |
200-day EMA: | 183.85 | Sell |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.1 | Sell |
20-day SMA: | 28.66 | Buy |
50-day SMA: | 27.88 | Buy |
200-day SMA: | 29.31 | Sell |
8-day EMA: | 28.88 | Buy |
20-day EMA: | 28.56 | Buy |
50-day EMA: | 28.37 | Buy |
200-day EMA: | 27.36 | Buy |
Diamondback Energy Earnings Growth & FANG Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.59 per share, an increase next quarter of $0.50 per share, an increase this year of $0.55 per share, and an increase next year of $0.91 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.24 per share, an increase this year of $9.51 per share, and an increase next year of $0.02 per share.
Diamondback Energy Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |